Research ArticleBasic Science Investigations
Vascular Targeted Radioimmunotherapy for the Treatment of Glioblastoma
Katja Behling, William F. Maguire, José Carlos López Puebla, Shanna R. Sprinkle, Alessandro Ruggiero, Joseph O'Donoghue, Philip H. Gutin, David A. Scheinberg and Michael R. McDevitt
Journal of Nuclear Medicine October 2016, 57 (10) 1576-1582; DOI: https://doi.org/10.2967/jnumed.115.171371
Katja Behling
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
William F. Maguire
2Department of Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, New York
José Carlos López Puebla
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
Shanna R. Sprinkle
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
Alessandro Ruggiero
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
Joseph O'Donoghue
3Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York
Philip H. Gutin
4Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York
5Department of Neurological Surgery, Weill Cornell Medical College, New York, New York
David A. Scheinberg
2Department of Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, New York
6Department of Pharmacology, Weill Cornell Medical College, New York, New York; and
Michael R. McDevitt
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
7Department of Medicine, Weill Cornell Medical College, New York, New York

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 57, Issue 10
October 1, 2016
Vascular Targeted Radioimmunotherapy for the Treatment of Glioblastoma
Katja Behling, William F. Maguire, José Carlos López Puebla, Shanna R. Sprinkle, Alessandro Ruggiero, Joseph O'Donoghue, Philip H. Gutin, David A. Scheinberg, Michael R. McDevitt
Journal of Nuclear Medicine Oct 2016, 57 (10) 1576-1582; DOI: 10.2967/jnumed.115.171371
Vascular Targeted Radioimmunotherapy for the Treatment of Glioblastoma
Katja Behling, William F. Maguire, José Carlos López Puebla, Shanna R. Sprinkle, Alessandro Ruggiero, Joseph O'Donoghue, Philip H. Gutin, David A. Scheinberg, Michael R. McDevitt
Journal of Nuclear Medicine Oct 2016, 57 (10) 1576-1582; DOI: 10.2967/jnumed.115.171371
Jump to section
Related Articles
Cited By...
- Glioblastoma Treatment by Systemic Actinium-225 {alpha}-particle Dendrimer-radioconjugates is Improved by Chemotherapy
- TAG-72-Targeted {alpha}-Radionuclide Therapy of Ovarian Cancer Using 225Ac-Labeled DOTAylated-huCC49 Antibody
- Leveraging Bioorthogonal Click Chemistry to Improve 225Ac-Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma
- {alpha}-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies--Part 2
- {alpha}-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies--Part 1
- Effect of densely ionizing radiation on cardiomyocyte differentiation from human-induced pluripotent stem cells
- Cure of Human Ovarian Carcinoma Solid Xenografts by Fractionated {alpha}-Radioimmunotherapy with 211At-MX35-F(ab')2: Influence of Absorbed Tumor Dose and Effect on Long-Term Survival